APAC Biodefense Market size to cross $5 Bn by 2028

Published Date: 2022-05-17

Request a sample

APAC Biodefense Market size is estimated to reach USD 5 billion by 2028, according to a latest forecast report by Graphical Research.

Rising bioterrorism activities, infectious diseases and chemicals, hazards of radiation exposure as well as fatal infections like avian influenza will stimulate the market. Additionally, growing usage of bio-agents, along with the growing demand for biosecurity, should propel the sector forward. Similarly, surge in research and development activities for early development of medical countermeasures against biological and chemical threats is projected to boost the market growth.

Based on product is bifurcated into biothreat detection and devices and vaccines. Vaccines is further categorized into, botulism, anthrax, smallpox, and others. Biothreat detection devices are further segmented into detectors/triggering devices assays, reagents, samplers, and identifiers. Out of these, the biothreat detection devices segment accounted for around 35% market share in 2021. The segmental growth is attributable to significant private and public sector investments in research and development activities, as well as the fact that the precision and functionality provided by these devices will increase their demand in the near future. Furthermore, the widespread availability of advanced biological threat detectors to ensure public safety will accelerate segment progress.

Browse detailed statistical insights from the report, “Asia Pacific Biodefense Market Forecast 2028 By Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays and Reagents}), Research Report, Country Outlook (Japan, China, India, Australia), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @


India biodefense industry will exhibit around 9.4% CAGR over the projected timeline. The country has strong coordination with health authorities, involvement of private actors, and awareness of biosecurity is likely to fuel the country level market growth. Additionally, with the release of pathogenic agents such as anthrax, biological toxins, chemical weapons such as nerve agents substances that have historically led to public threats in the country. The government has planned various strategies to prevent such havoc in future. For instance, India's Integrated Disease Monitoring Program (IDSP) is a decentralised, state-based surveillance programme was designed to provide early warning and prompt response to disease epidemics.

The biodefense in APAC market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2028, for the following segments:

Asia Pacific Market, By Product

  • Vaccines
    • Anthrax
    • Smallpox
    • Botulism
    • Others
  • Biothreat Detection Devices
    • Samplers
    • Detectors/Triggering Devices
    • Identifiers
    • Assays and Reagents

The above information has been provided for the following countries:

  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Others